3-Amino-1-propanesulfonic Acid CAS#3687-18-1

Promising Alzheimer’s Therapeutic Agent: 3-Aminopropanesulfonic acid displays notable potential as a candidate remedy for Alzheimer’s disease (AD).

Ongoing Late-Stage Clinical Research: This compound is now in Phase III clinical investigations across North America and Europe, marking major advances in its clinical advancement.

Validated Clinical Research Evidence: Published trial outcomes supply solid scientific proof to back up its therapeutic value.

Inhibits Cerebral Amyloid Build-Up: It attaches to soluble Aβ peptides to curb amyloid clustering, sedimentation and buildup inside the brain.

Product Description of 3-Amino-1-propanesulfonic Acid CAS#3687-18-1 3-Amino-1-propanesulfonic Acid stands out as a promising therapeutic agent targeting Alzheimer’s disease (AD). Late-stage Phase III clinical assessments are being carried out in North America and Europe, with relevant trial findings already released to the public. This active substance can attach to soluble Aβ peptides, which helps restrain amyloid clumping, sedimentation and buildup within brain tissue.1773711546746844.jpg.webp

3-Amino-1-propanesulfonic acid Chemical Properties

Melting point 293 °C (dec.)(lit.)
Density 1.202 (estimate)
Refractive index 1.5130 (estimate)
Storage temp2-8°C
Solubility Water (Slightly)
Pka1.06±0.50(Predicted)
Form Crystalline Powder
Color White to slightly blue
LogP-4.555
CAS DataBase Reference3687-18-1(CAS DataBase Reference)
Hazard Codes Xi
Risk Statements 36/37/38
Safety Statements 26-36
WGK Germany 1
HS Code 29049090

1773711583139078.jpg.webp

Product Application of 3-Amino-1-propanesulfonic Acid CAS#3687-18-1

The metabolic route of 3-aminopropanesulfonic acid largely defines its pharmacokinetic profiles and curative outcomes. Creating prodrugs and structural derivatives serves as an efficient approach to lift its therapeutic efficiency and bioavailability, for instance by boosting molecular stability or delaying metabolic degradation. Once administered, these altered variants can liberate the parent compound inside organisms and further raise its clinical application value.1773711595652873.jpg.webp

Online Consultation

Please fill out the form below and we will contact you as soon as possible